Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Staci D Arnold

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Haematology|June 20, 2026
Project Sickle Cure: A Prospective, International Observational Study of Hematopoietic Cell Transplantation for Sickle Cell DiseaseGregory M T Guilcher, Allistair Abraham, Staci D Arnold, et al.
JMIR Research Protocols|July 6, 2022
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility StudyLakshmanan Krishnamurti, Staci D Arnold, Ann Haight, et al.
Transplantation and Cellular Therapy|October 23, 2022
Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research AllianceElizabeth Stenger, Yijin Xiang, Martha Wetzel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2019
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) RegistriesMatt S Zinter, Brent R Logan, Caitrin Fretham, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Cancer Medicine|April 4, 2024
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity researchHaley Newman, Yimei Li, Yuan-Shung V Huang, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2020
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System AnalysisStaci D Arnold, Ruta Brazauskas, Naya He, et al.
Transplantation and Cellular Therapy|July 23, 2023
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR AnalysisBrandon J Blue, Ruta Brazauskas, Karen Chen, et al.
Haematologica|August 19, 2017
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databasesStaci D Arnold, Ruta Brazauskas, Naya He, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Haematology|June 20, 2026
Project Sickle Cure: A Prospective, International Observational Study of Hematopoietic Cell Transplantation for Sickle Cell DiseaseGregory M T Guilcher, Allistair Abraham, Staci D Arnold, et al.
JMIR Research Protocols|July 6, 2022
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility StudyLakshmanan Krishnamurti, Staci D Arnold, Ann Haight, et al.
Transplantation and Cellular Therapy|October 23, 2022
Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research AllianceElizabeth Stenger, Yijin Xiang, Martha Wetzel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2019
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) RegistriesMatt S Zinter, Brent R Logan, Caitrin Fretham, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Cancer Medicine|April 4, 2024
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity researchHaley Newman, Yimei Li, Yuan-Shung V Huang, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2020
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System AnalysisStaci D Arnold, Ruta Brazauskas, Naya He, et al.
Transplantation and Cellular Therapy|July 23, 2023
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR AnalysisBrandon J Blue, Ruta Brazauskas, Karen Chen, et al.
Haematologica|August 19, 2017
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databasesStaci D Arnold, Ruta Brazauskas, Naya He, et al.
Pageof 4